Symbiox Investment & Trading Co. Ltd. has submitted a regulatory compliance letter addressed to The Calcutta Stock Exchange Limited, The Bombay Stock Exchange Limited, and the Metropolitan Stock Exchange of India Limited.
The disclosure is made pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company confirms that it did not raise any funds through a Public Issue, Rights Issue, Preferential Issue, or Qualified Institutions Placement (QIP) during the quarter ended 30th September, 2026.
As a result of having no fundraising activity in the stated quarter, the requirement to submit a statement of deviation or variation in the utilization of funds is not applicable to the company.
The letter was signed by the Company Secretary & Compliance Officer (Membership No. A25950) and requests acknowledgment from the exchanges.